Cargando…
Osteopontin inhibits osteoarthritis progression via the OPN/CD44/PI3K signal axis
Chondrocyte degeneration and extracellular matrix component loss are the primary causes of osteoarthritis (OA). OA can be treated by inhibiting chondrocyte degeneration and increasing extracellular matrix component secretion. Osteopontin (OPN), a multifunctional protein, has gained immense attention...
Autores principales: | Liu, Qing, Zeng, Hao, Yuan, Yuhao, Wang, Zhiwei, Wu, Ziyi, Luo, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720673/ https://www.ncbi.nlm.nih.gov/pubmed/35005113 http://dx.doi.org/10.1016/j.gendis.2020.06.006 |
Ejemplares similares
-
Osteopontin (OPN) alleviates the progression of osteoarthritis by promoting the anabolism of chondrocytes
por: Luo, Wei, et al.
Publicado: (2022) -
Mechanistic Insight on the Interaction between OPN and Integrin ανβ3 in Osteoarthritis
por: Yuan, Yuhao, et al.
Publicado: (2020) -
LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance
por: Zhai, Xiangyu, et al.
Publicado: (2022) -
Cellular senescence-driven transcriptional reprogramming of the MAFB/NOTCH3 axis activates the PI3K/AKT pathway and promotes osteosarcoma progression
por: Zhang, Zhenhao, et al.
Publicado: (2023) -
Osteopontin mediated eosinophils activation by group II innate lymphoid cells
por: Zeng, Qingxiang, et al.
Publicado: (2022)